Skip to content

Advertisement

BMC Infectious Diseases

What do you think about BMC? Take part in

Hepatitis and co-infections

Section edited by Jean-Claude Desenclos

This section aims to publish studies looking at all aspects of the prevention, diagnosis and management of hepatitis in humans as well as related molecular genetics, pathophysiology, and epidemiology

Previous Page Page 1 of 7 Next Page
  1. Content type: Research article

    There are few data available on the prevalence, incidence, and residual risk of transfusion-transmitted HBV (TT-HBV) infections among Chinese blood donors. This study investigated the demographic characteristi...

    Authors: Ling Li, Tingting Han, Liang Zang, Libin Niu, Weifang Cheng, Hongkeng Lin, Ka Yi Li, Ruan Cao, Binghai Zhao, Yuqiang Liu, Guojin Ou, Xiao Liu, Yingjie Qi, Yanhua Li and Zhong Liu

    Citation: BMC Infectious Diseases 2017 17:754

    Published on:

  2. Content type: Research article

    Direct acting antivirals are expected to drastically reduce the burden of hepatitis C virus (HCV) in people living with Human Immunodeficiency Virus (HIV). However, rates of HCV testing, re-testing and inciden...

    Authors: David C. Boettiger, Matthew G. Law, Gregory J. Dore, Rebecca Guy, Denton Callander, Basil Donovan, Catherine C. O’Connor, Christopher K. Fairley, Margaret Hellard and Gail Matthews

    Citation: BMC Infectious Diseases 2017 17:740

    Published on:

  3. Content type: Research article

    Six distinct genetic variants (genotypes 1 − 6) of hepatitis C virus (HCV) exist globally. Certain genotypes are more prevalent in particular countries or regions than in others but, globally, genotype 3 (GT3)...

    Authors: Hosnieh Fathi, Andrew Clark, Nathan R. Hill and Geoffrey Dusheiko

    Citation: BMC Infectious Diseases 2017 17:722

    Published on:

  4. Content type: Research article

    Non-structural 5A protein (NS5A) resistance-associated substitutions (RASs) have been identified in patients infected with hepatitis C virus (HCV), even prior to exposure to direct-acting antiviral agents (DAA...

    Authors: Fernanda Malta, Karine Vieira Gaspareto, Gaspar Lisboa-Neto, Flair José Carrilho, Maria Cássia Mendes-Correa and João Renato Rebello Pinho

    Citation: BMC Infectious Diseases 2017 17:716

    Published on:

  5. Content type: Research article

    Schistosoma mansoni and Hepatitis C virus (HCV) are co-existence in sub-Saharan Africa and co-infection is common among humans population. The immunological responses characterized wit...

    Authors: Humphrey D. Mazigo, Stella Kepha, Godfrey M. Kaatano and Safari M. Kinung’hi

    Citation: BMC Infectious Diseases 2017 17:668

    Published on:

  6. Content type: Research article

    Hepatitis B Virus (HBV) infection is a worldwide public health problem. In Nepal, the prevalence of HBV is found to be low (0.9%), although high prevalence (≥8%) of HBV infection is depicted among subgroup/pop...

    Authors: Purusotam Raj Shedain, Madhu Dixit Devkota, Megha Raj Banjara, Huang Ling and Subash Dhital

    Citation: BMC Infectious Diseases 2017 17:667

    Published on:

  7. Content type: Research article

    For hepatitis B patients who do not meet the treatment criteria recommended by guidelines, therapy decisions depend on hepatic histology. Angiopoietin-like protein 2 (Angptl2) is a mediator of chronic inflamma...

    Authors: Yongqiong Deng, Hong Zhao, Jiyuan Zhou, Linlin Yan and Guiqiang Wang

    Citation: BMC Infectious Diseases 2017 17:650

    Published on:

  8. Content type: Research article

    Hepatitis B virus (HBV) affects people worldwide but the local burden especially in pregnant women and their new born babies is unknown. In Rwanda HIV-infected individuals who are also infected with HBV are su...

    Authors: Mwumvaneza Mutagoma, Helene Balisanga, Samuel S. Malamba, Dieudonné Sebuhoro, Eric Remera, David J. Riedel, Steve Kanters and Sabin Nsanzimana

    Citation: BMC Infectious Diseases 2017 17:618

    Published on:

  9. Content type: Research article

    Hepatitis B virus (HBV) infection is a major public health problem globally. HBV genotypes and subgenotypes influence disease transmission, progression, and treatment outcome. A study was conducted among treat...

    Authors: Thi Ton Taht Bui, Tan Thanh Tran, My Ngoc Nghiem, Pierre Rahman, Thi Thanh Thanh Tran, Man Nguyen Huy Dinh, Manh Hung Le, Van Vinh Chau Nguyen, Guy Thwaites and Motiur Rahman

    Citation: BMC Infectious Diseases 2017 17:601

    Published on:

  10. Content type: Research article

    Hepatitis B virus (HBV) infection is a major cause of chronic liver disease worldwide. In immunocompromised patients, the chronicity rates of HBV infection are higher, but the rates of hepatitis Be antigen (HB...

    Authors: Fatima Mitiko Tengan, Edson Abdala, Marisa Nascimento, Wanderley Marques Bernardo and Antonio Alci Barone

    Citation: BMC Infectious Diseases 2017 17:587

    Published on:

  11. Content type: Case report

    HBV reactivation is associated with high mortality rates in hematopoietic stem cell transplantation (HSCT) and prophylactic lamivudine (LMV) treatment is suggested to prevent this phenomenon. However, the dura...

    Authors: C. Cerva, G. Maffongelli, V. Svicher, R. Salpini, L. Colagrossi, A. Battisti, B. Mariotti, R. Cerretti, L. Cudillo and L. Sarmati

    Citation: BMC Infectious Diseases 2017 17:566

    Published on:

  12. Content type: Research article

    Hepatitis A virus (HAV) is a food and water-borne virus causing clinical (mainly hepatitis) and subclinical disease in humans. It is important to characterize circulating strains of HAV in order to prevent HAV...

    Authors: Huseyin Yilmaz, Asiye Karakullukcu, Nuri Turan, Utku Y. Cizmecigil, Aysun Yilmaz, Ayse A. Ozkul, Ozge Aydin, Alper Gunduz, Mahmut Mete, Fadile Y. Zeyrek, Taner T. Kirazoglu, Juergen A. Richt and Bekir Kocazeybek

    Citation: BMC Infectious Diseases 2017 17:561

    Published on:

  13. Content type: Research article

    Data on the cost effectiveness of hepatitis B virus (HBV) screening and vaccination strategies for prevention of vertical transmission of HBV in resource limited settings is sparse.

    Authors: Angela Devine, Rebecca Harvey, Aung Myat Min, Mary Ellen T. Gilder, Moo Koh Paw, Joy Kang, Isabella Watts, Borimas Hanboonkunupakarn, François Nosten and Rose McGready

    Citation: BMC Infectious Diseases 2017 17:552

    Published on:

  14. Content type: Research article

    Extensively Drug-Resistant (XDR) Tuberculosis (TB) has posed a great threat to global health and finance systems, especially for developing countries with high TB and Multidrug-Resistant (MDR) TB burden.

    Authors: Xiao-chun He, Ning-ning Tao, Yao Liu, Xian-xin Zhang and Huai-chen Li

    Citation: BMC Infectious Diseases 2017 17:555

    Published on:

  15. Content type: Research article

    Lack of Hepatitis C virus (HCV) incidence data in (Norwegian) high-risk groups impedes the ability to make informed decisions on prevention measures. Thus we rely on modelling to estimate the incidence and bur...

    Authors: Hinta Meijerink, Richard A White, Astrid Løvlie, Birgitte Freiesleben de Blasio, Olav Dalgard, Ellen J. Amundsen, Espen Melum and Hilde Kløvstad

    Citation: BMC Infectious Diseases 2017 17:541

    Published on:

  16. Content type: Research article

    Liver-related mortality has been increasing worldwide. We aimed to estimate the age-standardized mortality rates from viral hepatitis in Brazil.

    Authors: Hugo Perazzo, Antonio G Pacheco, Paula M Luz, Rodolfo Castro, Chris Hyde, Juliana Fittipaldi, Caroline Rigolon, Sandra W Cardoso, Beatriz Grinsztejn and Valdiléa G Veloso

    Citation: BMC Infectious Diseases 2017 17:527

    Published on:

  17. Content type: Research article

    Hepatitis A virus (HAV) infection is endemic in Eastern European and Balkan region countries. In 2012, Bulgaria showed the highest rate (67.13 cases per 100,000) in Europe. Nevertheless, HAV genotypes and stra...

    Authors: Roberto Bruni, Stefania Taffon, Michele Equestre, Eleonora Cella, Alessandra Lo Presti, Angela Costantino, Paola Chionne, Elisabetta Madonna, Elitsa Golkocheva-Markova, Diljana Bankova, Massimo Ciccozzi, Pavel Teoharov and Anna Rita Ciccaglione

    Citation: BMC Infectious Diseases 2017 17:497

    Published on:

  18. Content type: Research article

    Hepatitis E is self-limiting, but can cause death in most at risk groups like pregnant women and those with preexisting acute liver disease. In developing countries it presents as epidemic, in 2014 Hepatitis E...

    Authors: Geofrey Amanya, Samuel Kizito, Immaculate Nabukenya, Joan Kalyango, Collins Atuheire, Hellen Nansumba, Stephen Akena Abwoye, Denis Nixon Opio, Edrisa Kibuuka and Charles Karamagi

    Citation: BMC Infectious Diseases 2017 17:451

    Published on:

  19. Content type: Research article

    Treatment for chronic hepatitis B (CHB) is virtually absent in sub-Saharan Africa. Here we present early experiences from a pilot program for treatment of CHB in Ethiopia.

    Authors: Hanna Aberra, Hailemichael Desalegn, Nega Berhe, Girmay Medhin, Kathrine Stene-Johansen, Svein Gunnar Gundersen and Asgeir Johannessen

    Citation: BMC Infectious Diseases 2017 17:438

    Published on:

  20. Content type: Research article

    The aims of this analysis were to investigate treatment completion and adherence among people with ongoing injecting drug use or receiving opioid substitution therapy (OST) in a study of response-guided therap...

    Authors: Evan B. Cunningham, Behzad Hajarizadeh, Olav Dalgard, Janaki Amin, Margaret Hellard, Graham R Foster, Philip Bruggmann, Brian Conway, Markus Backmund, Geert Robaeys, Tracy Swan, Philippa S. Marks, Sophie Quiene, Tanya L Applegate, Martin Weltman, David Shaw…

    Citation: BMC Infectious Diseases 2017 17:420

    Published on:

Previous Page Page 1 of 7 Next Page

2016 Journal Metrics

Advertisement